We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

67 hedge funds and large institutions have $796M invested in Stoke Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 15

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

5% more funds holding

Funds holding: 64 → 67 (+3)

3.24% more ownership

Funds ownership: 102.3% → 105.54% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

16% less capital invested

Capital invested by funds: $948M → $796M (-$152M)

Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
29
Reduced
15
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$28.3M
2
BlackRock
BlackRock
New York
+$11.2M
3
AG
Artal Group
Luxembourg
+$6.18M
4
Victory Capital Management
Victory Capital Management
Texas
+$5.57M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.94M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$14.5M
2
SFM
Sphera Funds Management
Israel
-$5.66M
3
Millennium Management
Millennium Management
New York
-$5.16M
4
American Century Companies
American Century Companies
Missouri
-$4.06M
5
GGHC
Gilder Gagnon Howe & Co
New York
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
ALSV
1
ATP Life Science Ventures
New York
$384M – – –
RI
2
RTW Investments
New York
$81.2M – – –
RG
3
Redmile Group
California
$49.6M +$28.3M +1,145,160 +112%
CAM
4
Cormorant Asset Management
Massachusetts
$39.2M -$1.95M -78,878 -4%
GGHC
5
Gilder Gagnon Howe & Co
New York
$38.6M -$3.46M -140,143 -8%
BlackRock
6
BlackRock
New York
$31.4M +$11.2M +451,363 +49%
RCM
7
RA Capital Management
Massachusetts
$25.6M – – –
Federated Hermes
8
Federated Hermes
Pennsylvania
$19M +$1.41M +56,983 +7%
Vanguard Group
9
Vanguard Group
Pennsylvania
$18.2M +$573K +23,186 +3%
PA
10
Perceptive Advisors
New York
$15.4M – – –
Janus Henderson Group
11
Janus Henderson Group
United Kingdom
$12.2M -$14.5M -588,251 -53%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$10.7M -$2.18M -88,050 -16%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$9.79M -$1.51M -60,991 -12%
Victory Capital Management
14
Victory Capital Management
Texas
$9.28M +$5.57M +225,478 +126%
State Street
15
State Street
Massachusetts
$6.74M +$3.08M +124,537 +73%
AG
16
Artal Group
Luxembourg
$5.72M +$6.18M +250,000 New
Northern Trust
17
Northern Trust
Illinois
$4.61M +$2.07M +83,733 +71%
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$4.58M +$4.94M +200,000 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$4.26M +$1.63M +66,139 +55%
Lord, Abbett & Co
20
Lord, Abbett & Co
New Jersey
$4.18M +$4.51M +182,461 New
Wellington Management Group
21
Wellington Management Group
Massachusetts
$3M -$1.39M -56,068 -30%
CC
22
Casdin Capital
New York
$2.75M -$247K -10,000 -8%
Millennium Management
23
Millennium Management
New York
$2.6M -$5.16M -208,888 -65%
N
24
Nuveen
North Carolina
$1.97M +$1.6M +64,698 +302%
Charles Schwab
25
Charles Schwab
California
$1.61M +$432K +17,503 +33%
1
2 3 4

STOK Hedge Fund Activity: Q1 2020 in Review

67 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q1 2020, worth a combined $796M — down 16% from $948M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new STOK positions and 9 closed out — a net gain of 3 holders — while 29 added to existing stakes and 15 trimmed.

The largest buyer was Redmile Group, adding an estimated $28.3M. The largest seller was Janus Henderson Group, cutting an estimated $14.5M.

  • 67 institutional investors held Stoke Therapeutics (STOK) as of Q1 2020, up from 64 in Q4 2019.
  • Funds reported $796M of Stoke Therapeutics stock for Q1 2020, down 16% quarter-over-quarter.
  • 12 funds opened new Stoke Therapeutics positions in Q1 2020 and 9 closed out, a net change of +3 holders.
  • The largest Stoke Therapeutics buyer in Q1 2020 was Redmile Group, an estimated $28.3M added.
  • The largest Stoke Therapeutics seller in Q1 2020 was Janus Henderson Group, an estimated $14.5M sold.

Based on aggregated 13F filings for Q1 2020.